{"id":"https://openalex.org/W53235100","doi":null,"title":"\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306edopamine\u53d7\u5bb9\u4f53\u306b\u95a2\u3059\u308b\u7814\u7a76 \u7b2c2\u7de8 \u6297\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u85ac\u306a\u3089\u3073\u306b\u6297\u7cbe\u795e\u75c5\u85ac\u53cd\u5fa9\u6295\u4e0e\u306b\u3088\u308bdopamine\u53d7\u5bb9\u4f53\u306e\u8abf\u7bc0","display_name":"\u4e2d\u67a2\u795e\u7d4c\u7cfb\u306edopamine\u53d7\u5bb9\u4f53\u306b\u95a2\u3059\u308b\u7814\u7a76 \u7b2c2\u7de8 \u6297\u30d1\u30fc\u30ad\u30f3\u30bd\u30f3\u75c5\u85ac\u306a\u3089\u3073\u306b\u6297\u7cbe\u795e\u75c5\u85ac\u53cd\u5fa9\u6295\u4e0e\u306b\u3088\u308bdopamine\u53d7\u5bb9\u4f53\u306e\u8abf\u7bc0","publication_year":1982,"publication_date":"1982-04-01","ids":{"openalex":"https://openalex.org/W53235100","mag":"53235100"},"language":"ja","primary_location":{"id":"mag:53235100","doi":null,"is_oa":false,"landing_page_url":"http://escholarship.lib.okayama-u.ac.jp/files/public/1/16756/20160527215544688006/94_315.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306548074","display_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024745015","display_name":"Yasuhide Yamawaki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Yasuhide Yamawaki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5024745015"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00155726,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"94","issue":"3","first_page":"315","last_page":"330"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7886000275611877,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7886000275611877,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.10859999805688858,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0803999975323677,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-receptors","display_name":"dopamine receptors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.9269999861717224},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":1.0},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.800000011920929},{"id":"https://openalex.org/keywords/bromocriptine","display_name":"bromocriptine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.843999981880188},{"id":"https://openalex.org/keywords/antiparkinsonian-drugs","display_name":"antiparkinsonian drugs","score":0.9380000233650208},{"id":"https://openalex.org/keywords/receptor-supersensitivity","display_name":"receptor supersensitivity","score":0.7429999709129333},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.6930000185966492},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8899999856948853},{"id":"https://openalex.org/keywords/dopamine-sensitive-adenylate-cyclase","display_name":"dopamine-sensitive adenylate cyclase","score":0.7070000171661377},{"id":"https://openalex.org/keywords/radioreceptor-assay","display_name":"radioreceptor assay","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C2776856834","wikidata":"https://www.wikidata.org/wiki/Q413581","display_name":"Bromocriptine","level":4,"score":0.8659780025482178},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.8130573034286499},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.7051310539245605},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6273391842842102},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5344732403755188},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.5304934978485107},{"id":"https://openalex.org/C199596767","wikidata":"https://www.wikidata.org/wiki/Q21110872","display_name":"Dopamine receptor D3","level":4,"score":0.5243932604789734},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.485566109418869},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4591727554798126},{"id":"https://openalex.org/C160262196","wikidata":"https://www.wikidata.org/wiki/Q5376331","display_name":"Endogenous agonist","level":5,"score":0.4580392837524414},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37746694684028625},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37686386704444885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3334205448627472},{"id":"https://openalex.org/C120750228","wikidata":"https://www.wikidata.org/wiki/Q2035393","display_name":"Dopamine receptor D1","level":4,"score":0.33316540718078613},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.09319254755973816},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.07719415426254272}],"mesh":[],"locations_count":2,"locations":[{"id":"mag:53235100","doi":null,"is_oa":false,"landing_page_url":"http://escholarship.lib.okayama-u.ac.jp/files/public/1/16756/20160527215544688006/94_315.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306548074","display_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","raw_type":null},{"id":"mag:566568860","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/120002306533","pdf_url":null,"source":{"id":"https://openalex.org/S4306548074","display_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u5ca1\u5c71\u533b\u5b66\u4f1a\u96d1\u8a8c","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2617714947","https://openalex.org/W7113610684","https://openalex.org/W9836004","https://openalex.org/W1497648012","https://openalex.org/W2081793724","https://openalex.org/W2419023892","https://openalex.org/W1975216040","https://openalex.org/W3195607013","https://openalex.org/W159516817","https://openalex.org/W2026077845"],"abstract_inverted_index":{"Long-term":[0],"drug":[1,25],"studies":[2],"in":[3,56,68,147,187,203,231,253,277],"animals":[4],"using":[5,97],"antiparkinsonian":[6],"drugs":[7,52,112],"(L-dopa":[8],"and":[9,11,14,27,82,94,210,234],"bromocriptine)":[10],"neuroleptics":[12],"(chlorpromazine":[13],"haloperidol)":[15],"can":[16,28],"provide":[17],"valuable":[18],"clinical":[19],"information":[20],"on":[21,113,126],"the":[22,35,47,57,64,105,134,168,176,188,205,219,241,278],"mechanism":[23],"of":[24,34,38,50,107,110,116,152,181,207,224,246,262,274],"action":[26,49],"contribute":[29],"to":[30,77,133],"a":[31,71,83,100,271],"better":[32],"understanding":[33],"side":[36,264],"effects":[37,106,265],"such":[39],"therapy.":[40,166],"Moreover,":[41],"it":[42,60,257],"has":[43],"been":[44],"suggested":[45,259],"that":[46,63,123,193,260],"molecular":[48],"these":[51,111],"involves":[53],"dopamine":[54,65,78,117,275],"receptors":[55,184,200,227,276],"brain.":[58],"Recently,":[59],"was":[61,155,161,258],"proposed":[62],"receptor":[66,154,159,248],"exists":[67],"two":[69,114],"forms:":[70],"D(1)-dopamine":[72,153],"receptor,":[73,85],"which":[74,86],"is":[75,87,120],"coupled":[76],"sensitive":[79],"adenilate":[80],"cyclase,":[81],"D(2)-dopamine":[84,158,183,199,226,247],"uncoupled.":[88],"I":[89,103],"have":[90],"established":[91],"D(1)-dopamine-radioreceptor":[92],"assay":[93,96],"D(2)-dopamine-radioreceptor":[95],"[(3)H]-dopamine":[98],"as":[99],"ligand,":[101],"then":[102],"studied":[104],"chronic":[108],"administration":[109],"forms":[115],"receptors.":[118],"It":[119],"well":[121],"known":[122],"most":[124],"patients":[125],"prolonged":[127],"L-dopa":[128,165,211],"therapy":[129,196],"either":[130],"become":[131],"refractory":[132],"drug,":[135],"or":[136,140],"develop":[137],"on-off":[138],"phenomena":[139],"dyskinesias.":[141],"In":[142],"this":[143],"study,":[144],"an":[145],"increase":[146],"high":[148,177,220,242],"affinity":[149,178,221,243],"binding":[150,179,222,244],"sites":[151,180,223,245],"detected,":[156],"whereas":[157],"subsensitivity":[160],"observed":[162],"following":[163],"long-term":[164,194,267],"On":[167],"other":[169],"hand,":[170],"after":[171,235,266],"bromocriptine":[172,195,209],"treatment":[173,215,237,269],"for":[174,216,238],"14days,":[175],"D(1)-and":[182,198,225],"were":[185,228,249],"increased":[186,230,252],"rat":[189,232,254,279],"striatum.":[190,255,280],"The":[191],"finding":[192],"increases":[197],"may":[201],"explain,":[202],"part,":[204],"efficacy":[206],"combination":[208],"treatment.":[212],"After":[213],"chlorpromazine":[214],"14":[217,239],"days,":[218,240],"slightly":[229,251],"striatum,":[233],"haloperidol":[236],"also":[250],"Therefore,":[256],"symptoms":[261],"extrapyramidal":[263],"neuroleptic":[268],"reflect":[270],"functional":[272],"supersensitivity":[273]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}